ArchonBio emerges from Stealth

Archon Biosciences emerged from stealth with $20M (Madrona Ventures) in seed funding to develop AI-designed protein “cages” in order to amplify antibody treatments and streamline drug development. Archon’s goal is to enhance binding potential by clustering their cages in dodecahedral structures, enhancing their binding potential.